tiprankstipranks
Trending News
More News >

Brad's Biorunup - New Portfolio

Lazy Brad

Brad's Biorunup
Individual Investor
Ranked #348,180 out of 821,200 TipRanks' Investors
Success Rate
64%
28 out of 44
profitable transactions
Average Return
5.21%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 10.19%
6-Month Return▲ 65.78%
12-Month Return-
YTD Return▲ 37.52%
Total Return▲ 37.52%

Best Trade

Opened at
Closed at
Gain▲ 71.37%

Bio

As a serious and responsible investor, I secured my assets in a classic Lazy Portfolio, the old good 60/40. Can you imagine how boring it is? So the Mr. Hyde in me diverted some pocket $$ from it to cherry-pick this bunch of risky, volatile stocks.

Performance

32.43%0-32.43%
▼ 15.60%
▼ 5.57%
▼ 8.21%
Mar 2025
▼ 3.50%
▼ 0.87%
▲ 14.72%
Apr 2025
▲ 7.77%
▲ 6.28%
▲ 32.43%
May 2025
▲ 2.59%
▲ 5.14%
▼ 2.25%
Jun 2025
▲ 22.60%
▲ 2.30%
▼ 3.64%
Jul 2025
▼ 1.95%
▲ 2.05%
▲ 1.90%
Aug 2025
▲ 6.01%
▲ 3.56%
▲ 8.95%
Sep 2025
▲ 2.08%
▲ 0.46%
▲ 1.63%
Oct 2025
TipRanks AverageS&P 500Investor Portfolio
▼ 15.60%▼ 5.57%▼ 8.21%
▼ 3.50%▼ 0.87%▲ 14.72%
▲ 7.77%▲ 6.28%▲ 32.43%
▲ 2.59%▲ 5.14%▼ 2.25%
▲ 22.60%▲ 2.30%▼ 3.64%
▼ 1.95%▲ 2.05%▲ 1.90%
▲ 6.01%▲ 3.56%▲ 8.95%
▲ 2.08%▲ 0.46%▲ 1.63%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Kura Oncology
0%
▲ 10.79%
1
Open
Sep 19, 2025
Vanda
0%
▲ 14.92%
1
Open
Sep 19, 2025
Exelixis
0%
▲ 3.12%
1
Open
Sep 19, 2025
Intuitive Surgical
0%
▼ 24.86%
2
Sell
Sep 18, 2025
89bio
0%
▲ 34.79%
2
Sell
Sep 18, 2025
DoorDash
▲ 40.83%
3
Close
Sep 18, 2025
Biomea Fusion
0%
▲ 2.40%
1
Open
Sep 18, 2025
Fortress Biotech
0%
▼ 21.35%
1
Open
Sep 18, 2025
Arcutis Biotherapeutics
0%
▲ 19.99%
1
Open
Sep 18, 2025
Cidara Therapeutics
0%
▲ 38.30%
1
Open
Sep 18, 2025
Apogee Therapeutics
0%
▲ 3.07%
1
Open
Sep 18, 2025
Celldex
0%
▼ 0.27%
1
Open
Sep 18, 2025
Aclaris Therapeutics
0%
▼ 5.64%
1
Open
Sep 18, 2025
Adagio Medical Holdings
0%
▲ 10.44%
1
Open
Sep 18, 2025
Imunon
▲ 12.37%
2
Close
Jun 19, 2025
Doximity
▼ 1.21%
2
Close
Jun 19, 2025
Urogen Pharma
▲ 71.37%
2
Close
Jun 13, 2025
Protagonist Therapeutics
▲ 1.24%
2
Close
Jun 13, 2025
Regeneron
▲ 2.25%
2
Close
Jun 13, 2025
RegenXBio
0%
▲ 14.13%
1
Open
Jun 13, 2025